Dong Sung Bio Pharm.Co.,Ltd. (KOSE:A002210) announces a share repurchase program. Under the program, the company will repurchase up to 209,424 shares. The purpose behind the program is to improve shareholder value and to stabilize stock price. The repurchase program will expire on November 19, 2021. As of August 19, 2021, the company had 2,662,948 treasury shares within scope available for dividend and no shares in treasury through other repurchase.